Clinical Trial Update: Intracavernosal Injection of Botulinum Toxin Type A in the Treatment of Vascular Erectile Dysfunction [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating intracavernosal injection of botulinum toxin type A for vasculogenic erectile dysfunction; study completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction
• Vasculogenic Erectile Dysfunction

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Cairo University | Conditions: Vasculogenic Erectile Dysfunction | Phase 1 | Status: COMPLETED | Results posted: 2016-10-31